Literature DB >> 17762966

DNA stool test for colorectal cancer: hypermethylation of the secreted frizzled-related protein-1 gene.

Wei Zhang1, Michael Bauer, Roland S Croner, Jörg O W Pelz, Dimitri Lodygin, Heiko Hermeking, Michael Stürzl, Werner Hohenberger, Klaus E Matzel.   

Abstract

PURPOSE: To investigate a potential mode of noninvasive screening for colorectal cancer, we evaluated the hypermethylation of the secreted frizzled-related protein-1 gene promoter in human stool DNA.
METHODS: In stool samples from 36 patients with colorectal neoplasia (7 adenoma, 29 colorectal cancer) and 17 healthy control subjects, isolated DNA was treated with sodium bisulfite and analyzed by methylation-specific polymerase chain reaction with primers specific for methylated or unmethylated promoter sequences of the secreted frizzled-related protein-1 gene.
RESULTS: Hypermethylation of the secreted frizzled-related protein-1 promoter was present in the stool DNA of patients with adenoma and colorectal cancer. A sensitivity of 89 percent and specificity of 86 percent were achieved in the detection of colorectal neoplasia. The difference in hypermethylation status of the secreted frizzled-related protein-1 promoter between the patients with colorectal neoplasia and the control group was statistically highly significant (P < 0.001). Adenoma and early tumor Stage I (International Union Against Cancer) displayed both unmethylated and methylated secreted frizzled-related protein-1 promoter sequences, whereas advanced tumor stages showed only methylated secreted frizzled-related protein-1 (P = 0.05).
CONCLUSIONS: The results indicate that this DNA stool test of hypermethylation of the secreted frizzled-related protein-1 promoter is a sensitive and specific method. It has the potential of a clinically useful test for the early detection of colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17762966     DOI: 10.1007/s10350-007-0286-6

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  24 in total

1.  Detection of DNA hypermethylation in remote media of patients with colorectal cancer: new biomarkers for colorectal carcinoma.

Authors:  Andreas Herbst; Frank T Kolligs
Journal:  Tumour Biol       Date:  2012-02-24

2.  Screening for differentially methylated genes among human colorectal cancer tissues and normal mucosa by microarray chip.

Authors:  Wei Chen; Jun Xiang; De-Feng Chen; Bei-Bei Ni; Hao Chen; Xin-Juan Fan; Pu-Ning Wang; Shun-Xin Song; Le-Kun Fang; Huan-Yu Xiao; Lei Wang; Jian-Ping Wang
Journal:  Mol Biol Rep       Date:  2013-03-08       Impact factor: 2.316

3.  DNA Methylation and Colorectal Cancer.

Authors:  Hassan Ashktorab; Hassan Brim
Journal:  Curr Colorectal Cancer Rep       Date:  2014-12-01

4.  Distinct WNT/β-catenin signaling activation in the serrated neoplasia pathway and the adenoma-carcinoma sequence of the colorectum.

Authors:  Takashi Murakami; Hiroyuki Mitomi; Tsuyoshi Saito; Michiko Takahashi; Naoto Sakamoto; Naoshi Fukui; Takashi Yao; Sumio Watanabe
Journal:  Mod Pathol       Date:  2014-06-13       Impact factor: 7.842

5.  Sessile serrated adenomas and classical adenomas: an epigenetic perspective on premalignant neoplastic lesions of the gastrointestinal tract.

Authors:  Mashaal Dhir; Shinichi Yachida; Leander Van Neste; Sabine C Glöckner; Jana Jeschke; Emmanouil P Pappou; Elizabeth A Montgomery; James G Herman; Stephen B Baylin; Christine Iacobuzio-Donahue; Nita Ahuja
Journal:  Int J Cancer       Date:  2011-03-11       Impact factor: 7.396

Review 6.  Accuracy of early detection of colorectal tumours by stool methylation markers: a meta-analysis.

Authors:  Hu Zhang; Jian Qi; Ya-Qiong Wu; Ping Zhang; Jun Jiang; Qi-Xian Wang; You-Qing Zhu
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

Review 7.  Genetic and epigenetic marker-based DNA test of stool is a promising approach for colorectal cancer screening.

Authors:  Sung Whan An; Nam Kyu Kim; Hyun Cheol Chung
Journal:  Yonsei Med J       Date:  2009-06-23       Impact factor: 2.759

8.  Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer.

Authors:  Sabine C Glöckner; Mashaal Dhir; Joo Mi Yi; Kelly E McGarvey; Leander Van Neste; Joost Louwagie; Timothy A Chan; Wolfram Kleeberger; Adriaan P de Bruïne; Kim M Smits; Carolina A J Khalid-de Bakker; Daisy M A E Jonkers; Reinhold W Stockbrügger; Gerrit A Meijer; Frank A Oort; Christine Iacobuzio-Donahue; Katja Bierau; James G Herman; Stephen B Baylin; Manon Van Engeland; Kornel E Schuebel; Nita Ahuja
Journal:  Cancer Res       Date:  2009-05-12       Impact factor: 12.701

9.  Epigenetic regulation of WNT signaling pathway genes in inflammatory bowel disease (IBD) associated neoplasia.

Authors:  Mashaal Dhir; Elizabeth A Montgomery; Sabine C Glöckner; Kornel E Schuebel; Craig M Hooker; James G Herman; Stephen B Baylin; Susan L Gearhart; Nita Ahuja
Journal:  J Gastrointest Surg       Date:  2008-08-21       Impact factor: 3.452

10.  Toward a comprehensive and systematic methylome signature in colorectal cancers.

Authors:  Hassan Ashktorab; Hamed Rahi; Daniel Wansley; Sudhir Varma; Babak Shokrani; Edward Lee; Mohammad Daremipouran; Adeyinka Laiyemo; Ajay Goel; John M Carethers; Hassan Brim
Journal:  Epigenetics       Date:  2013-07-10       Impact factor: 4.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.